TITLE

ATS bioprosthesis implanted in Switzerland

PUB. DATE
January 2010
SOURCE
Medical Device Daily;1/26/2010, Vol. 14 Issue 16, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article deals with the first commercial implants of the ATS 3f Enable Aortic Bioprosthesis performed at the University of Berne Hospital in Berne, Switzerland as reported by ATS Medical.
ACCESSION #
47734489

 

Related Articles

  • ATS receives Australian OK for 3f Aortic Bioprosthesis.  // Medical Device Daily;2/9/2009, Vol. 13 Issue 25, p1 

    The article reports on the announcement by cardiac surgery products and services provider ATS Medical that the Australian Therapeutic Goods Administration has granted approval for commercialization of the tissue valve ATS 3f Aortic Bioprosthesis. According to the company, the device is a...

  • ATS 3f heart valve implanted in robot-assisted procedure. PEDERSEN, AMANDA // Medical Device Daily;11/4/2009, Vol. 13 Issue 213, p1 

    The article reports that the first human robot assisted endoscopic aortic valve replacement using the daVinci Surgical System from Intuitive Surgical to implant ATS Medical's 3f Aortic Bioprosthesis has been performed at Banner Baywood Health Hospital in Phoenix, Arizona. Allen Raczkowski, the...

  • Continuing Medical Education: Infections of Cardiovascular Implantable Electronic Devices.  // New England Journal of Medicine;9/27/2012, Vol. 367 Issue 13, p1272 

    A correction to the article "Continuing Medical Education: Infections of Cardiovascular Implantable Electronic Devices" that was published in "The New England Journal of Medicine" in 2012 is presented.

  • Infections of Cardiovascular Implantable Electronic Devices.  // New England Journal of Medicine;10/11/2012, Vol. 367 Issue 15, p1474 

    A correction to the article "Infections of Cardiovascular Implantable Electronic Devices" that was published in the 2012 issue is presented.

  • Heart-assist device approved.  // FDA Consumer;Dec94, Vol. 28 Issue 10, p2 

    Reports that the Food and Drug Administration (FDA) approved the first implantable heart-assist device on September 30, 1994. Hopes for improved chances of survival for patients waiting for a heart transplant; The Heartmate Implantable Pneumatic Left Ventricular Assist System.

  • Drug-eluting balloons data indicate therapeutic potential. Bechtel, Brian; Ellis, Brian; Fisher, Stacey; Harris, Jason; Kalvaitis, Katie; Southall, Jennifer; Volansky, Rob; Zacharyczuk, Colleen // Cardiology Today;Nov2010, Vol. 13 Issue 11, p18 

    This article reveals that there is a consensus among a panel of researchers on the potential of drug-eluting balloons in various cardiovascular applications based on completed and ongoing trials.

  • Ape Gets Heart Implant.  // Current Health 1;Feb2005, Vol. 28 Issue 6, p7 

    Reports on a cardiac resynchronization therapy (CRT) device given to Babec, a gorilla with a heart disease in Birmingham, Alabama.

  • Implantable radial pump assists damaged hearts. King, Russell H. // Design News;6/12/95, Vol. 51 Issue 11, p107 

    Focuses on the use of implantable ventricular-assist devices (VADs) in assisting damaged or diseased hearts pump blood. Cleveland Clinic's unique VAD design; Solution of clotting and damage problems; Design of motor components.

  • Technology. Montague, Jim // H&HN: Hospitals & Health Networks;11/20/96, Vol. 70 Issue 22, p14 

    Presents information on Heart-Mate pumps, battery-powered left ventricular-assist devices for use by heart disease patients awaiting donors. Implantation of the pumps in three patients; Instruction of patients on the use of the pumps.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics